These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19736707)

  • 21. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.
    Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
    J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
    Hemphill LC
    J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
    de Lorgeril M
    World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of familial hypercholesterolaemia in children and adolescents.
    Justo RN
    J Paediatr Child Health; 2012 Feb; 48(2):E53-8. PubMed ID: 22017319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.
    Raal FJ; Pappu AS; Illingworth DR; Pilcher GJ; Marais AD; Firth JC; Kotze MJ; Heinonen TM; Black DM
    Atherosclerosis; 2000 Jun; 150(2):421-8. PubMed ID: 10856535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A boy with autosomal recessive hypercholesterolaemia.
    Rodenburg J; Wiegman A; Vissers MN; Kastelein JJ; Stalenhoef AF
    Neth J Med; 2004 Mar; 62(3):89-93. PubMed ID: 15209474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of familial hypercholesterolaemia.
    Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
    Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A keen eye for risk.
    Ford TJ; Rocchiccioli P
    BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393
    [No Abstract]   [Full Text] [Related]  

  • 38. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group.
    Sun XM; Patel DD; Knight BL; Soutar AK
    Atherosclerosis; 1998 Jan; 136(1):175-85. PubMed ID: 9544745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ENHANCE results: a surrogate trial that impacts beyond size and scope.
    Cardiovasc J Afr; 2008; 19(3):166-8. PubMed ID: 18568183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.